Effects of jinlida granules on renin-angiotensin system in kidney and cardiovascular tissues of diabetic rats

Academic Journal of Second Military Medical University

Volumn 33, Issue 10, 2012, Pages 1065-1069

  Wu, Ying ^a   Shi, Jing li ^a   Song, Yu ping ^a   Han, Chong ^a   Liang, Cui ^a   Liu, Zhi min ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular system; Diabetes mellitus; Jinlida granules; Kidney; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; CHINESE DRUG;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HEART MASS; HEART PROTECTION; KIDNEY; KIDNEY MASS; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WESTERN BLOTTING;

EID: 84974517808     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1008.2012.01065     Document Type: Article

References (21)

1. Savoia C, Volpe M. Angiotensin receptor modulation and cardiovascular remodeling [J]. J Renin Angiotensin Aldosterone Syst, 2011, 12:381-384.
2. Adcghate E, Kalasz H, Veress G, Teke K. Medicinal chemistry of drugs used in diabetic cardiomyopathy[J]. Curr Med Chem, 2010, 17:517-551.
3. Abdel-Rahman E M, Abadir P M, Siragy H M. Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by Angiotensin ATI and AT2 receptors[J]. Am J Physiol Regul Integr Comp Physiol, 2008, 295: R1473-R1478.
4. Lu T, Zhang DM, Wang XL, He T, Wang RX, Chai Q, et al. Regulation of coronary arterial BK channels by caveolae-mediated angiotensin II signaling in diabetes mellitus[J]. Circ Res. 2010, 106:1164-1173.
5. Wenzel UO, Krebs C, Benndorf R. The Angiotensin II type 2 receptor in renal disease [J]. J Renin Angiotensin Aldosterone Syst, 2010, 11:37-41.
6. Chinese Source
7. Chinese Source
8. Rossing K, Jacobsen P, Pietraszek L, Parving HH. Renoprotective effects of adding Angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial [J]. Diabetes Care, 2003, 26:2268-2274.
9. Ogawa S, Mori T, Nako K, Kato T, Takeuchi K, Ito S. Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy [J]. Hypertension, 2006, 47:699-705.
10. Chinese Source
11. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression [J]. Circ Res, 1998, 83: 1035-1046.
12. Sechi LA, Griffin CA, Schambelan M. The cardiac rcnin-angio-tensin system in STZ-induced diabetes [J]. Diabetes, 1994, 43: 1180-1184.
13. Yang ZH, Peng XD. Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus [J]. Chin Med J (Engl), 2010, 123:3640-3643.
14. Yaghini FA, Song CY, Lavrentyev EN, Ghafoor HU, Fang XR, Estes AM, et al. Angiotensin II -induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 lBl-dependent superoxide generation[J]. Hypertension, 2010, 55:1461-1467.
15. Touyz R M, Schiffrin E L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of Angiotensin II in vascular smooth muscle cells [J]. Pharmacol Rev, 2000, 52:639-672.
16. Chinese Source
17. Chinese Source
18. Chinese Source
19. Chinese Source
20. Chinese Source
21. Shi JL, Wu Y, Song YP, Han C, Liu ZM. Protective effect of Jinlida granules on islet (3 cells in diabetes mellitus rats [J]. Acad J Sec Mil Med Univ, 2012, 33:385-389.